American Heartworm Society

Thanks to the generosity of the Symposium Benefactors all meals and social functions are complimentary

Friday, July 13, 2007

8:00AM-5:30PM

Session1 – Heartworms & Pharmacogenomics: Application Now and the Future

  • Canine MDR1 (ABCB1) and Avermectins: Heartworm Prevention and Pharmacogenomics
    Katrina Mealey, DVM Washington State University
  • Applying Comparative and Functional Genomics to Filariae and Their Control
    James McCarter, MD, Ph.D. Divergence, Inc. St. Louis. MO
  • Heartworm and Genomics
    Panel Discussion

Session2: Wolbachia / Dirofilaria immitis Interactions

  • Association of Wolbachia with Heartworm Disease in Dogs and Cats
    Julie Levy, DVM, University of Florida
  • Wolbachia, Its in-Vitro Effect on Endothelial Mammal Cells
    Fernando Simon Ph.D. University of Salamanca, Spain
  • Wolbachia and Its Influence on the Pathology and Immunology of Dirofilaria Immitis Infections
    Laura Kramer, DVM, University of Parma, Italy
  • Heartworm and Wolbachia: Therapeutic Implications
    John McCall, Ph.D., University of Georgia

Session3: Developments with Heartworms in Dogs

  • Incidence of Positive Heartworm Antibody and Antigen Tests at IDEXX Laboratories:Trends and Potential Impact on HARD Awareness and Prevention
    Anthony Caola, Ph.D.
  • An Epidemiological Analysis of the Proheart6 Experience
    Lawrence Glickman, VMD, DrPH, Purdue University
  • Heartworm Preventive Failures – Resistance or Client Compliance?
    Byron Blagburn, Ph.D, Auburn University

Saturday, July 14, 2007

8:00AM-5:30PM

Session4: H.A.R.D. Pathophysiology and Preventive Research

  • Acute Death in Heartworm Infected Cats: Unraveling the Puzzle
    Annette Litster, BVSc, PhD, FACVS Queensland, Australia
  • Statistical Elaboration of Life Expectancy, Cause of Death and Duration of Infection in Cats Infected
    D. immitis, Claudio Genchi, DVM, University of Parma, Italy
  • The Pathophysiology of Feline Heartworm – An Update
    Ray Dillon, DVM, Auburn University
  • Safety of Advantage Multi™ (10 % Imidacloprid + 1% Moxidectin) Topical Solution Applied toCats Infected with Adult Heartworms (Dirofilaria immitis) Using a Natural Infection Model
    Dr. Robert Arther, DVM, Shawnee Mission, Kansas

Session5: H.A.R.D. Diagnostics: State of the Feline Heartworm

  • Echocardiographic Quantification of Heartworm Burdens in Cats
    Clarke Atkins, DVM, North Carolina State University
  • Radiographic Findings in the Asymptomatic Cat
    Luigi Venco, DVM, University of Milan, Italy
  • Diagnostic Challenges in Feline Heartworm Infections
    Julia Levy, DVM, University of Florida

Sunday July 15, 2007

8:00AM-11:45PM

American Heartworm Society President’s Program – Held at the AVMA Convention Center

You must be registered for the AVMA meeting in order to attend this session

  • Wolbachia and Its Influence on the Pathology and Immunology of Dirofilaria immitis Infections
    Laura Kramer, DVM, University of Parma, Italy
  • The Pathophysiology of Feline Heartworm Disease, An Update
    Ray Dillon, DVM, Auburn University
  • Diagnostic Challenges in Feline Heartworm Infections
    Julia Levy, DVM, University of Florida
  • Heartworm Preventive Failures – Resistance or Client Compliance?
    Byron Blagburn, Ph.D., Auburn, University
Share.

Comments are closed.